Skin cancer triage and management during COVID-19 pandemic
Open Access
- 31 May 2020
- journal article
- editorial
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (6), 1136-1139
- https://doi.org/10.1111/jdv.16529
Abstract
The worldwide medical community is striving to pursue the most appropriate clinical choices in the worst event of pandemic of the modern times [1], with over 1 million patients affected by COVID‐19 (i.e., swab positive patients with or without symptoms) reported so far [1]. In this context, the aim of the ideal management of cancer patients is to achieve the best possible balance between the two different issues to be considered, which include the risk of cancer progression and the risk of infectious disease.This publication has 5 references indexed in Scilit:
- European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2020
- Global coronavirus pandemic (2019-nCOV): implication for an Italian medium size dermatological clinic of a II level hospitalJournal of the European Academy of Dermatology and Venereology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJama-Journal Of The American Medical Association, 2020
- Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreakInternational Journal of Radiation Oncology*Biology*Physics, 2020
- The response of Milan's Emergency Medical System to the COVID-19 outbreak in ItalyThe Lancet, 2020